







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Strassheim and Williams 275 (50): 39767</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Pierce%20banner&url=http://www.piercenet.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1054134641.gif" ALT="Pierce - The Protein People(tm)"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue50/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39767">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M007775200v1">doi:10.1074/jbc.M007775200</A> on September 19, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 50, 39767-39772, December 15, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/50/39767">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/50/39767">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/50/39767">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/50/39767&title=P2Y2+Purinergic+and+M3+Muscarinic+Acetylcholine+Receptors+Activate+Different+Phospholipase+C-beta++Isoforms+That+Are+Uniquely+Susceptible+to+Protein+Kinase+C-dependent+Phosphorylation+and+Inactivation">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007775200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10995776&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10995776&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Strassheim+D&link_type=AUTHORSEARCH">Strassheim, D.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Williams+CL&link_type=AUTHORSEARCH">Williams, C. L.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/50/39767&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39767"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/50/39767">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/50/39767<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007775200v1">M007775200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    P2Y<SUB>2</SUB> Purinergic and M<SUB>3</SUB> Muscarinic
Acetylcholine Receptors Activate Different Phospholipase C-<IMG SRC="/math/12pt/Large/beta.gif" ALIGN=BASELINE ALT="beta ">
Isoforms That Are Uniquely Susceptible to Protein Kinase
C-dependent Phosphorylation and Inactivation<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>



<STRONG>
<NOWRAP>
Derek 
Strassheim and<WBR>
Carol L. 
Williams<A HREF="#FN152"><SUP><IMG SRC="/math/12pt/normal/link/Dagger.gif" ALIGN=BASELINE ALT="Dagger" BORDER=0></SUP></A>
</NOWRAP>
</STRONG>
<P>
From the Molecular Pharmacology Laboratory, Guthrie Research
Institute, Sayre, Pennsylvania 18840
<P>
Received for publication, August 25,&nbsp;2000, and in revised form, September 18,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<BR CLEAR=ALL><A NAME="Abstract"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Activation of phospholipase C-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">) by
G protein-coupled receptors typically results in rapid but
transient second messenger<SUP> </SUP>generation. Although PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> deactivation
may contribute to the<SUP> </SUP>transient nature of this response, the mechanisms
governing PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>deactivation are poorly characterized. We
investigated the involvement<SUP> </SUP>of protein kinase C (PKC</A>) in the
termination of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation<SUP> </SUP>induced by endogenous
P2Y<SUB>2</SUB> purinergic receptors and transfected<SUP> </SUP>M<SUB>3</SUB> muscarinic acetylcholine receptors (mAChR</A>) in Chinese
hamster<SUP> </SUP>ovary cells. Activation of P2Y<SUB>2</SUB> receptors causes
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> to associate<SUP> </SUP>with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, whereas M<SUB>3</SUB>
mAChR</A> activation causes G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> to associate<SUP> </SUP>with both
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 in these cells. Phosphorylation of<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, but
not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, is induced by activating either P2Y<SUB>2</SUB>
receptors<SUP> </SUP>or M<SUB>3</SUB> mAChR</A>. We demonstrate that PKC</A> rather than
protein kinase<SUP> </SUP>A mediates the G protein-coupled receptor-induced
phosphorylation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3. The PKC-mediated phosphorylation of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 diminishes<SUP> </SUP>the interaction of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, thereby contributing to<SUP> </SUP>the termination PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 activity.
These findings indicate that<SUP> </SUP>the distinct temporal profiles of PLC
activation by P2Y<SUB>2</SUB> receptors<SUP> </SUP>and mAChR</A> may arise from the
differential activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1<SUP> </SUP>and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 by the receptors,
coupled with a selective PKC-mediated<SUP> </SUP>negative feedback mechanism that
targets PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<BR CLEAR=ALL><A NAME="Introduction"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Phosholipase C-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
(PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">)<SUP>1</SUP> is a key signal
transduction enzyme catalyzing the hydrolysis of phosphatidylinositol
4,5-bisphosphate<SUP> </SUP>to yield the second messengers inositol
1,4,5-trisphosphate (IP<SUB>3</SUB></A>)<SUP> </SUP>and
1,2-<I>sn</I>-diacylglycerol (<A HREF="#B1">1-3</A>). IP<SUB>3</SUB></A> mobilizes
[Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB>, whereas
1,2-<I>sn</I>-diacylglycerol activates protein kinase<SUP> </SUP>C (PKC</A>) (<A HREF="#B1">1</A>,
<A HREF="#B2">2</A>, <A HREF="#B4">4</A>). Both PKC</A> and [Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB> exert pleiotropic
effects on signal transduction pathways<SUP> </SUP>in the cell. Many cell surface
receptors activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, including<SUP> </SUP>a significant proportion of the
members of the super family of<SUP> </SUP>G protein-coupled receptors (GPCRs) (<A HREF="#B2">2</A>).
GPCRs activate four<SUP> </SUP>isozymes of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">4) encoded by
different genes (reviewed<SUP> </SUP>in Refs. <A HREF="#B3">3</A> and <A HREF="#B5">5</A>). Activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> by
GPCRs typically<SUP> </SUP>occurs very rapidly and is usually detectable within
3&nbsp;s (<A HREF="#B6">6-11</A>).<SUP> </SUP>Subsequent deactivation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> can also occur
rapidly, causing<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity to subside within 20-90 s after the
activation<SUP> </SUP>of some GPCRs (<A HREF="#B7">7</A>, <A HREF="#B8">8</A>). However, PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> deactivation
sometimes<SUP> </SUP>occurs much more slowly, resulting in sustained PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
activity<SUP> </SUP>even 10-30 min after GPCR</A> activation (<A HREF="#B6">6-9</A>). The mechanism of<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation is fairly well characterized and involves the<SUP> </SUP>interaction of activated G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> proteins with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (<A HREF="#B2">2</A>,
<A HREF="#B3">3</A>,<SUP> </SUP><A HREF="#B5">5</A>). In contrast, the mechanisms contributing to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> deactivation<SUP> </SUP>are complex and not well<SUP> </SUP>understood.
</P>
<P>Multiple events may contribute to the rapid termination of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
activity after GPCR</A> activation. The phosphorylation and internalization<SUP> </SUP>of activated GPCRs may diminish GPCR-mediated signaling to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">,<SUP> </SUP>causing PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity to subside (<A HREF="#B12">12</A>, <A HREF="#B13">13</A>). GTPase-mediated<SUP> </SUP>inactivation of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> proteins (<A HREF="#B14">14-16</A>) may inhibit the ability of<SUP> </SUP>G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> proteins to activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, further diminishing
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity.<SUP> </SUP>Another proposed mechanism for PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> deactivation
is the phosphorylation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> itself (<A HREF="#B17">17</A>, <A HREF="#B18">18</A>). Recent studies
indicate that the<SUP> </SUP>PKC-mediated phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 may limit
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 activity<SUP> </SUP>induced by platelet-activating factor in phagocytes
(<A HREF="#B17">17</A>) and<SUP> </SUP>by the activation of opioid receptors in neuroblastoma cells
(<A HREF="#B18">18</A>).<SUP> </SUP>These findings support the previously proposed model that PKC</A><SUP> </SUP>acts in a negative feedback loop to limit PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity (<A HREF="#B4">4</A>,<SUP> </SUP><A HREF="#B17">17</A>, <A HREF="#B18">18</A>).
Recent studies indicate that protein kinase A (PKA</A>)<SUP> </SUP>can also
phosphorylate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 and limit its activity (<A HREF="#B19">19</A>). However,<SUP> </SUP>this
latter reported mechanism represents cross-regulation from<SUP> </SUP>adenylyl
cyclase to PLC signaling systems and not classic negative<SUP> </SUP>feedback.
Such cross-regulation is an unlikely mechanism for the<SUP> </SUP>termination of
GPCR-activated PLC activity, because most G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>-coupled<SUP> </SUP>GPCRs do not activate adenylyl cyclase. Thus, it is not clear<SUP> </SUP>whether
PKC</A> or PKA</A> plays a more important role in agonist-induced<SUP> </SUP>phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. Additionally, it has not been determined<SUP> </SUP>how PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> phosphorylation may limit PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>activity.
</P>
<P>PKC activation diminishes GPCR-mediated IP<SUB>3</SUB></A> generation and
Ca<SUP>2+</SUP> mobilization in many cell types (<A HREF="#B9">9</A>, <A HREF="#B17">17</A>, <A HREF="#B18">18</A>, <A HREF="#B20">20</A>, <A HREF="#B21">21</A>),<SUP> </SUP>indicating that PKC</A> is a plausible candidate to directly inhibit<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity. However, PKC</A> may act on proteins other than PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>to limit IP<SUB>3</SUB></A> generation and Ca<SUP>2+</SUP> mobilization
after GPCR</A> stimulation. For example, it has been<SUP> </SUP>reported that
PKC-mediated phosphorylation may directly inhibit<SUP> </SUP>the activities of
certain GPCRs (<A HREF="#B22">22</A>, <A HREF="#B23">23</A>) as well as the Ca<SUP>2+</SUP> channels through
which Ca<SUP>2+</SUP> enters cells after GPCR</A> stimulation (<A HREF="#B24">24</A>). These
potentially<SUP> </SUP>numerous targets for PKC-mediated inhibition make it
difficult<SUP> </SUP>to determine unambiguously where PKC</A> acts to limit PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>activity.
</P>
<P>The purpose of this study was to determine the role of PKC</A> in the
poorly characterized termination of GPCR-stimulated PLC<SUP> </SUP>activity. We
investigated PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity regulated by endogenous<SUP> </SUP>P2Y<SUB>2</SUB>
purinergic receptors (<A HREF="#B25">25</A>) and transfected M<SUB>3</SUB> muscarinic<SUP> </SUP>acetylcholine receptors (mAChR</A>) (<A HREF="#B11">11</A>) expressed in Chinese hamster<SUP> </SUP>ovary
(CHO</A>) cells. It was previously reported that P2Y<SUB>2</SUB>
receptors,<SUP> </SUP>like most GPCRs, transiently activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (<A HREF="#B25">25</A>), whereas
M<SUB>3</SUB><SUP> </SUP>mAChR</A> activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> for periods longer than 10&nbsp;min
(<A HREF="#B6">6</A>, <A HREF="#B9">9</A>,<SUP> </SUP><A HREF="#B11">11</A>). We found that P2Y<SUB>2</SUB> receptors functionally
couple only to<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, whereas M<SUB>3</SUB> mAChR</A> functionally
couple to both PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 in CHO</A> cells. Activating
P2Y<SUB>2</SUB> receptors or M<SUB>3</SUB> mAChR</A> induces<SUP> </SUP>the
phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, in these cells.<SUP> </SUP>We
demonstrate that PKC</A>, rather than PKA</A>, mediates the GPCR-induced<SUP> </SUP>phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3. Thus, PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation does not<SUP> </SUP>result from cross-regulation by adenylyl cyclase acting on PLC<SUP> </SUP>signaling. Our results indicate that PKC</A> participates in a negative<SUP> </SUP>feedback loop to inhibit the interaction of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3,<SUP> </SUP>limiting the duration of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 activity. This PKC-mediated
negative<SUP> </SUP>regulation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, coupled with the differential
activation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 by M<SUB>3</SUB> mAChR</A> and
P2Y<SUB>2</SUB> receptors, offers a mechanism<SUP> </SUP>for the distinct
temporal profiles of PLC activation by these<SUP> </SUP>two<SUP> </SUP>receptors.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Reagents--</I>

Rabbit polyclonal antibodies to
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>, PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Horseradish<SUP> </SUP>peroxidase-labeled
anti-rabbit antibodies, ECL reagents and [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S
(specific activity, 1030&nbsp;Ci/mmol) were purchased from<SUP> </SUP>Amersham
Pharmacia Biotech. [<SUP>32</SUP>P]Orthophosphate (specific
activity, 74&nbsp;Ci/mmol) and [<SUP>35</SUP>S]cysteine/methionine
(specific activity, 1200&nbsp;Ci/mmol) were purchased<SUP> </SUP>from ICN (Costa Mesa,
CA). The fluorescent dye Fura-2 AM and pluronic<SUP> </SUP>were purchased from
Molecular Probes (Eugene, OR). Dithiobis[succinimidyl<SUP> </SUP>propionate] was
obtained from Pierce. All other reagents were<SUP> </SUP>purchased from Sigma
unless otherwise noted in the<SUP> </SUP>text.



    

    


<P><I>Cell Culture--</I>

CHO-K1 sublines stably transfected with the
M<SUB>3</SUB> subtype of human mAChR</A> were maintained in complete
medium consisting of Ham's<SUP> </SUP>F-12 medium (Cellgro Mediatech, Herndon,
VA) containing 5% calf<SUP> </SUP>bovine serum (Hyclone Laboratories, Logan, UT),
glutamine (0.3<SUP>&nbsp;</SUP>mg/ml), penicillin (20&nbsp;units/ml), and streptomycin
sulfate (20<SUP>&nbsp;</SUP>&#181;g/ml). Cells were maintained at 37&nbsp;&#176;C in a humidified
atmosphere<SUP> </SUP>of 5% CO<SUB>2</SUB>/95% air at densities that promoted
exponential<SUP> </SUP>proliferation.



    

    


<P><I>Metabolic Labeling--</I>

For <SUP>35</SUP>S labeling, cells were
incubated for 12&nbsp;h in cysteine- and methionine-free Ham's F-12
medium containing 20% normal Ham's<SUP> </SUP>F-12 medium and 50&nbsp;&#181;Ci/ml
[<SUP>35</SUP>S]cysteine/methionine, from ICN (Costa Mesa, CA). For
<SUP>32</SUP>P labeling, cells were incubated for 90&nbsp;min in
phosphate-free<SUP> </SUP>Dulbecco's modified Eagle's medium containing 10&nbsp;m<font size=-1>M</font> HEPES, pH<SUP> </SUP>7.4,&nbsp;and 30&nbsp;&#181;Ci/ml
[<SUP>32</SUP>P]orthophosphoric<SUP> </SUP>acid.



    

    


<P><I>Immunoprecipitation of PLC<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1/<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3--</I>

Labeled cells were
challenged with agonists for various times and subsequently lysed in
immunoprecipitation buffer (50&nbsp;m<font size=-1>M</font><SUP> </SUP>HEPES, pH 7.4,&nbsp;130&nbsp;m<font size=-1>M</font> NaCl, 1&nbsp;m<font size=-1>M</font> MgCl<SUB>2</SUB>, 1&nbsp;m<font size=-1>M</font> CaCl<SUB>2</SUB>, 40&nbsp;m<font size=-1>M</font>
KH<SUB>2</SUB>PO<SUB>4</SUB>,<SUP> </SUP>1% Triton X-100, 0.5% Nonidet P-40,
0.2% bovine serum albumin,<SUP> </SUP>15% glycerol, 50&nbsp;m<font size=-1>M</font> sodium
fluoride, 1&nbsp;m<font size=-1>M</font> sodium orthovanadate).<SUP> </SUP>The lysate was
centrifuged at 13,000&nbsp;&#215;&nbsp;<I>g</I> for 10&nbsp;min, and the
resulting<SUP> </SUP>supernatant was rotated (90&nbsp;min, 4&nbsp;&#176;C) with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or
-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 antibodies<SUP> </SUP>and protein A-agarose beads (Life Technologies, Inc.).
After washing<SUP> </SUP>three times in lysis buffer, the immunoprecipitates were
eluted<SUP> </SUP>with sample buffer (30&nbsp;min, 4&nbsp;&#176;C), subjected to SDS-PAGE,
electrophoretically<SUP> </SUP>transferred to PVDF</A> membranes, and subjected to<SUP> </SUP>autoradiography.



    

    


<P><I>Co-immunoprecipitation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> with
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>--</I>

Co-immunoprecipitation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q</SUB> has been described previously (<A HREF="#B26">26</A>). CHO</A>
cells were incubated for 2&nbsp;h<SUP> </SUP>in serum-free medium and exposed to
agonists for 1&nbsp;min in the<SUP> </SUP>presence of 1&nbsp;m<font size=-1>M</font>
dithiobis[succinimidyl propionate] to induce<SUP> </SUP>protein cross-linking
and subsequently lysed in immunoprecipitation<SUP> </SUP>buffer described above.
The lysate was centrifuged at 13,000&nbsp;g<SUP> </SUP>for 10&nbsp;min, and the resulting
supernatant was rotated (90&nbsp;min,<SUP> </SUP>4&nbsp;&#176;C) with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/ll</SUB>
antibody and protein A-agarose beads (Life Technologies,<SUP> </SUP>Inc.). After
washing three times in lysis buffer, the immunoprecipitates<SUP> </SUP>were
eluted with sample buffer (30&nbsp;min, 4&nbsp;&#176;C), subjected to SDS-PAGE,<SUP> </SUP>and
electrophoretically transferred to PVDF</A> membranes. The PVDF</A><SUP> </SUP>membranes
were blocked and probed by ECL-Western blotting as described<SUP> </SUP>below
using antibodies to G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/ll</SUB>, PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3.



    

    


<P><I>ECL-Western Blotting--</I>

Cells were lysed by periodic agitation
for 15&nbsp;min in ice-cold lysis buffer (50&nbsp;m<font size=-1>M</font> Tris-HCl, 120&nbsp;m<font size=-1>M</font> NaCl, 2.5&nbsp;m<font size=-1>M</font> EDTA, 1&nbsp;m<font size=-1>M</font><SUP> </SUP>dithiothreitol, and 0.5% Nonidet P-40, pH 7.4) containing protease<SUP> </SUP>inhibitors (400&nbsp;&#181;<font size=-1>M</font> phenylmethylsulfonyl fluoride and 20&nbsp;&#181;g/ml<SUP> </SUP>leupeptin) and phosphatase inhibitors (10&nbsp;m<font size=-1>M</font> sodium
fluoride,<SUP> </SUP>1&nbsp;m<font size=-1>M</font> sodium orthovanadate, 0.2&nbsp;m<font size=-1>M</font>
sodium PP<SUB>i</SUB>, and 10&nbsp;m<font size=-1>M</font> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-glycerophosphate).<SUP> </SUP>After centrifugation (16,000&nbsp;&#215;&nbsp;<I>g</I> for 10&nbsp;min at
4&nbsp;&#176;C), the supernatants<SUP> </SUP>were diluted with lysis buffer to equal
protein concentrations<SUP> </SUP>and boiled for 5&nbsp;min with sample buffer (75&nbsp;m<font size=-1>M</font> Tris-HCl, 2% SDS,<SUP> </SUP>10% glycerol, 5%
<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-mercaptoethanol, and 0.005% bromphenol blue,<SUP> </SUP>pH 6.8). Aliquots
containing equal protein concentrations were<SUP> </SUP>subjected to SDS-PAGE
using a 5% stacking gel and a 10% separating<SUP> </SUP>gel and
electrophoretically transferred to PVDF</A> membranes. The<SUP> </SUP>blocked PVDF</A>
membranes were incubated with antibodies to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1<SUP> </SUP>or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3,
followed by incubation with horseradish peroxidase-labeled<SUP> </SUP>anti-rabbit
antibodies. Bound antibody was visualized by ECL and<SUP> </SUP>quantified by<SUP> </SUP>densitometry.



    

    


<P><I>Binding of [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S to
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>--</I>

Binding of [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S to
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> was determined by modification of a method
described previously (<A HREF="#B26">26</A>). CHO</A> cells were washed<SUP> </SUP>in phosphate-buffered
saline, suspended in reaction buffer (50<SUP>&nbsp;</SUP>m<font size=-1>M</font> HEPES, 100&nbsp;m<font size=-1>M</font> NaCl, 6&nbsp;m<font size=-1>M</font> MgCl<SUB>2</SUB>, 2&nbsp;m<font size=-1>M</font> EDTA, 10&nbsp;&#181;<font size=-1>M</font> GDP, 150&nbsp;n<font size=-1>M</font><SUP> </SUP>GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S, pH 7.4), and subjected to a <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">70&nbsp;&#176;C freeze/thaw cycle to<SUP> </SUP>disrupt cell membranes. The freeze/thawed cells were incubated<SUP> </SUP>for 15&nbsp;min (37&nbsp;&#176;C), with 30&nbsp;n<font size=-1>M</font> [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S in
the absence or presence of agonists for 10&nbsp;min (37<SUP> </SUP>&#176;C). The samples
were solubilized by rocking in lysis buffer (50<SUP>&nbsp;</SUP>m<font size=-1>M</font> HEPES,
150&nbsp;m<font size=-1>M</font> NaCl, 20&nbsp;m<font size=-1>M</font> MgCl<SUB>2</SUB>, 100&nbsp;&#181;<font size=-1>M</font> GDP, 100&nbsp;&#181;<font size=-1>M</font> GTP, 0.5%<SUP> </SUP>Nonidet P-40, 1&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl fluoride, 200&nbsp;&#181;g/ml leupeptin,<SUP> </SUP>pH
7.4). The samples were centrifuged (13,000&nbsp;&#215;&nbsp;<I>g</I>, 10&nbsp;min, 4&nbsp;&#176;C),<SUP> </SUP>and the resulting supernatants were incubated (1.5&nbsp;h,
4&nbsp;&#176;C) with<SUP> </SUP>G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/ll</SUB> antibody and protein A-agarose. The
immunoprecipitates<SUP> </SUP>bound to protein A-agarose were washed two times in
lysis buffer,<SUP> </SUP>resuspended in distilled water, and transferred to
scintillation<SUP> </SUP>vials containing Ultima-Gold scintillation fluid (Packard
Bioscience).<SUP> </SUP>The amounts of [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S bound to the
immunoprecipitated G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/ll</SUB> were determined<SUP> </SUP>by liquid
scintillation counting using an LS-6000 <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-counter.



    

    


<P><I>Measurement of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>-stimulated PLC Activity in
Membranes--</I>

CHO</A> cells were labeled for 24&nbsp;h in Ham's F-12
medium containing 5% fetal bovine serum and 5&nbsp;&#181;Ci/ml
[<SUP>3</SUP>H]<I>myo</I>-inositol. The cells were washed in
phosphate-buffered saline,<SUP> </SUP>suspended in reaction buffer (described
above), and subjected<SUP> </SUP>to a <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">70&nbsp;&#176;C freeze/thaw cycle to disrupt cell
membranes. Membranes<SUP> </SUP>were challenged with GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S for 10&nbsp;min, 37&nbsp;&#176;C,
after which the<SUP> </SUP>supernatant was removed for determination of released
inositol<SUP> </SUP>phosphates by liquid scintillation counting as described
previously<SUP> </SUP>(<A HREF="#B9">9</A>, <A HREF="#B27">27</A>).



    

    


<P><I>Measurement of PLA<SUB>2</SUB> Activity--</I>

Arachidonic acid
release was measured as an indictor of phospholipase A<SUB>2</SUB>
activity as described previously (<A HREF="#B28">28</A>). CHO</A> cells<SUP> </SUP>were plated in 24-well
culture plates at a density of 2.5&nbsp;&#215;&nbsp;10<SUP>5</SUP> cells/ml in
Ham's F-12 medium containing 5% fetal bovine serum.<SUP> </SUP>After incubation
for 48&nbsp;h, the medium was supplemented with 0.2<SUP>&nbsp;</SUP>mCi/ml
[<SUP>3</SUP>H]arachidonic acid, and the cells were incubated
overnight. The<SUP> </SUP>cells were rinsed three times in Ham's F-12 medium,
followed by<SUP> </SUP>a 1-h incubation in Ham's F-12 medium containing 5% fetal
bovine<SUP> </SUP>serum. Cells were exposed to carbachol for 15&nbsp;min, and an
aliquot<SUP> </SUP>of the culture supernatant was subjected to liquid
scintillation<SUP> </SUP>counting to determine [<SUP>3</SUP>H]arachidonic acid<SUP> </SUP>content.



    

    


<P><I>Ca<SUP>2+</SUP> Mobilization--</I>

Cells attached to glass
coverslips were incubated for 45&nbsp;min at 37&nbsp;&#176;C in Dulbecco's
modified Eagle's medium containing 10<SUP>&nbsp;</SUP>m<font size=-1>M</font> HEPES, pH 7.4,&nbsp;0.28&nbsp;mg/ml probenecid, 0.03% pluronic F127,<SUP> </SUP>and 2&nbsp;&#181;g/ml FURA-2 AM in
a humidified atmosphere of 5% CO<SUB>2</SUB>/95%<SUP> </SUP>air. The cells were
washed three times in Dulbecco's modified<SUP> </SUP>Eagle's medium containing
10&nbsp;m<font size=-1>M</font> HEPES, pH 7.4,&nbsp;and 0.28&nbsp;mg/ml<SUP> </SUP>probenecid. The ratio
of intracellular Fura-2 fluorescence at<SUP> </SUP>340&nbsp;and 380&nbsp;n<font size=-1>M</font> was
measured with a CMX Scanning Cation Microilluminator<SUP> </SUP>(Instruments,
S.&nbsp;A., Edison, NJ). Ratios were converted to intracellular<SUP> </SUP>Ca<SUP>2+</SUP> concentrations as described previously (<A HREF="#B9">9</A>, <A HREF="#B26">26</A>).



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>To determine which PLC isoforms are expressed by CHO-m3 cells,
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 were immunoprecipitated from <SUP>35</SUP>S-labeled
CHO</A> cells, submitted to SDS-PAGE, and visualized by<SUP> </SUP>autoradiography
(Fig. <a href="#F1">1</a><I>A</I>). By this method we
found that significant<SUP> </SUP>levels of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 are expressed by
these cells. In contrast,<SUP> </SUP>neither PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2 nor -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">4 could be detected
in immunoprecipitates<SUP> </SUP>or immunoblots of the CHO-m3 cells (Fig.
<a href="#F1">1</a><I>B</I>).



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=176 SRC="/content/vol275/issue50/images/small/bc4909341001.gif"></A><BR>

<STRONG>View larger version</STRONG> (30K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F1"
onClick="startTarget('F1', 590, 588); this.href='/cgi/content-nw/full/275/50/39767/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>CHO</B></A><B> cells express
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but
do not express detectable levels of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2 or
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">4.</B> <I>A</I>, lysates prepared
from <SUP>35</SUP>S-labeled CHO</A> cells were immunoprecipitated using
antibodies to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 (<I>lane 2</I>) or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (<I>lane
4</I>) or using rabbit nonimmune serum (<I>lanes 1</I>&nbsp;and
<I>3</I>). The immunoprecipitates were subjected to SDS-PAGE
followed by autoradiography. The efficiency of immunoprecipitation was
determined by comparing the immunoreactivity of 5% of lysis material
with the total recovered in immunoprecipitation (data not shown).
<I>B</I>, lysates prepared from CHO</A> cells (<I>lanes 1</I>&nbsp;and
<I>3</I>), U937 cells (<I>lane 2</I>), or mouse brain tissues
(<I>lane 4</I>) were probed by ECL-Western blotting using
antibodies to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">2 (<I>lanes 1</I>&nbsp;and <I>2</I>) or
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">4 (<I>lanes 3</I>&nbsp;and <I>4</I>). Results are
representative of three independent experiments that produced similar
results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->




    
    </P>

    
    <P>Previous studies indicate that GPCR</A> activation can induce
phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 isoforms (<A HREF="#B17">17-19</A>). We investigated this<SUP> </SUP>phenomenon by immunoprecipitating PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 from
<SUP>32</SUP>P-labeled CHO-m3 cells exposed to carbachol or ATP. Both
of these<SUP> </SUP>agonists induced a rapid and dose-dependent
phosphorylation of<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (Figs. <a href="#F2">2</a> and
<a href="#F3">3</a>) but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 (Fig. <a href="#F3">3</a>). Carbachol
and<SUP> </SUP>ATP typically stimulated 4-fold and 3-fold increases in PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>phosphorylation above basal levels, respectively. These results<SUP> </SUP>indicate that PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and -<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 are regulated differently by GPCR</A><SUP> </SUP>activation in these cells.



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=133 SRC="/content/vol275/issue50/images/small/bc4909341002.gif"></A><BR>

<STRONG>View larger version</STRONG> (27K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F2"
onClick="startTarget('F2', 590, 492); this.href='/cgi/content-nw/full/275/50/39767/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 is
phosphorylated by the activation of M<SUB>3</SUB> </B><B>mAChR</B></A><B> or
P2Y<SUB>2</SUB> receptors in </B><B>CHO</B></A><B> cells.</B> PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was
immunoprecipitated from <SUP>32</SUP>P-labeled CHO</A> cells that were
incubated with 10&nbsp;&#181;<font size=-1>M</font> carbachol for different times
(<I>A</I>), different carbachol concentrations for 5&nbsp;min
(<I>B</I>), 10&nbsp;&#181;<font size=-1>M</font> ATP for different times
(<I>C</I>), or different ATP concentrations for 10&nbsp;min
(<I>D</I>). The immunoprecipitates were subjected to SDS-PAGE
followed by autoradiography. Similar results were obtained in two other
independent experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->







<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=87 SRC="/content/vol275/issue50/images/small/bc4909341003.gif"></A><BR>

<STRONG>View larger version</STRONG> (28K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F3"
onClick="startTarget('F3', 590, 391); this.href='/cgi/content-nw/full/275/50/39767/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is not
detectably phosphorylated by the activation of M<SUB>3</SUB> </B><B>mAChR</B></A><B> or
P2Y<SUB>2</SUB> receptors in </B><B>CHO</B></A><B> cells.</B> PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was
immunoprecipitated from <SUP>32</SUP>P-labeled CHO</A> cells that were
incubated with 10&nbsp;&#181;<font size=-1>M</font> carbachol, 10&nbsp;&#181;<font size=-1>M</font> ATP,
or 50&nbsp;n<font size=-1>M</font> PMA</A> for the indicated times. The
immunoprecipitates were subjected to SDS-PAGE followed by
autoradiography (<I>top</I>) or ECL-Western blotting using
antibodies to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, as indicated (<I>bottom</I>).
Results are representative of three independent experiments that
produced similar results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->




    
    </P>

    
    <P>Confusion exists regarding the kinases mediating the GPCR-stimulated
phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. Several studies have indicated<SUP> </SUP>roles for
both PKC</A> (<A HREF="#B17">17</A>, <A HREF="#B18">18</A>) and PKA</A> (<A HREF="#B19">19</A>). It is more likely<SUP> </SUP>that PKC</A>, rather than
PKA</A>, acts in a classical negative feedback<SUP> </SUP>loop to mediate rapid PLC
phosphorylation and deactivation. The<SUP> </SUP>involvement of PKA</A> may indicate
cross-regulation, which is unlikely<SUP> </SUP>to be a mechanism for rapid PLC
phosphorylation and deactivation,<SUP> </SUP>because G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>-coupled
receptors do not generally activate adenylyl<SUP> </SUP>cyclase. The ability of
PKA</A> to mediate agonist-induced phosphorylation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was tested
using the highly specific PKA</A> antagonist,<SUP> </SUP>Rp-CAMPS. Concentrations of
Rp-CAMPS well above those known to<SUP> </SUP>completely block PKA</A> activation (<A HREF="#B28">28</A>,
<A HREF="#B29">29</A>) had no effect on<SUP> </SUP>the carbachol-induced phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3
at (Fig. <a href="#F4">4</a>). This<SUP> </SUP>finding indicates that
PKA</A> does not participate in PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation<SUP> </SUP>induced by the
M<SUB>3</SUB> mAChR</A>. The inability of PKA</A> to mediate carbachol-induced<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation is not due to an inability of PKA</A> to
phosphorylate<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, because activation of PKA</A> with forskolin
induces PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>phosphorylation (Fig. <a href="#F4">4</a>).



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=145 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4909341004.gif"></A><BR>

<STRONG>View larger version</STRONG> (32K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F4"
onClick="startTarget('F4', 468, 640); this.href='/cgi/content-nw/full/275/50/39767/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>PKC</B></A><B>, but not </B><B>PKA</B></A><B>, participates in
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation induced by
M<SUB>3</SUB> </B><B>mAChR</B></A><B> or P2Y<SUB>2</SUB> receptor activation.</B>
<I>A</I>, <SUP>32</SUP>P-labeled CHO</A> cells were incubated for 10&nbsp;min in the absence or presence of 10&nbsp;&#181;<font size=-1>M</font> BIM</A> prior to
challenge with 10&nbsp;&#181;<font size=-1>M</font> ATP, 10&nbsp;&#181;<font size=-1>M</font> carbachol,
or 50&nbsp;n<font size=-1>M</font> PMA</A> for 10&nbsp;min, as indicated. PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was
immunoprecipited from the lysed cells and subjected to SDS-PAGE
followed by autoradiography. <I>B</I>, <SUP>32</SUP>P-labeled CHO</A>
cells were incubated for 10&nbsp;min with the indicated concentrations of
PMA</A>. PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was immunoprecipited from the lysed cells and
subjected to SDS-PAGE followed by autoradiography, as indicated.
<I>C</I>, <SUP>32</SUP>P-labeled CHO</A> cells were incubated with 50&nbsp;n<font size=-1>M</font> PMA</A> for the indicated times. PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was
immunoprecipited from the lysed cells and subjected to SDS-PAGE
followed by autoradiography. <I>D</I>, <SUP>32</SUP>P-labeled CHO</A>
cells were incubated with 10&nbsp;&#181;<font size=-1>M</font> carbachol for 10&nbsp;min
(<I>lanes 2-6</I>). Prior to carbachol exposure, the cells were
preincubated for 15&nbsp;min with the PKA</A> inhibitor Rp-CAMPS at
concentrations of 0&nbsp;&#181;<font size=-1>M</font> (<I>lane 2</I>), 25&nbsp;&#181;<font size=-1>M</font> (<I>lane 3</I>), 50&nbsp;&#181;<font size=-1>M</font> (<I>lane
4</I>), 100&nbsp;&#181;<font size=-1>M</font> (<I>lane 5</I>), or 200&nbsp;&#181;<font size=-1>M</font> (<I>lane 6</I>). Alternatively, the
<SUP>32</SUP>P-labeled cells were untreated (<I>lane 1</I>) or
exposed to 50&nbsp;&#181;<font size=-1>M</font> forskolin for 5&nbsp;min (<I>lane 7</I>)
or 15&nbsp;min (<I>lane 8</I>). PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was immunoprecipited from the
lysed cells and subjected to SDS-PAGE followed by autoradiography.
Similar results were obtained in two other independent
experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->




    
    </P>

    
    <P>In contrast to the effects of inactivating PKA</A>, inactivation of PKC</A>
with the specific antagonist BIM</A> significantly inhibited<SUP> </SUP>the carbachol-
or ATP-induced phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (Fig.<SUP> </SUP><a href="#F4">4</a><I>A</I>). This
finding indicates that PKC</A> participates in the agonist-induced<SUP> </SUP>phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3. Further evidence that PKC</A> mediates<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation is provided by our finding that PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>is
phosphorylated when PKC</A> is directly activated by PMA</A> (Figs.<SUP> </SUP><a href="#F3">3</a> and <a href="#F4">4</a>).
PMA</A> typically increased PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation 3-4-fold<SUP> </SUP>above basal
levels. Interestingly, activation of PKC</A> does not<SUP> </SUP>induce the
phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 (Fig. <a href="#F4">4</a><I>B</I>). This finding suggests<SUP> </SUP>that the lack of agonist-induced phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is<SUP> </SUP>due to
an inability of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 to serve as a substrate for PKC-mediated<SUP> </SUP>phosphorylation in these<SUP> </SUP>cells.
    
    </P>

    
    <P>The mechanism by which PKC</A> inhibits PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> is poorly characterized. We
found that treatment with PMA</A> diminishes GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S-stimulated<SUP> </SUP>inositol
polyphosphate generation in the CHO-m3 cells (Fig.
<a href="#F5">5</a>).<SUP> </SUP>This result indicates that PKC</A>
stimulation diminishes the ability<SUP> </SUP>of GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S to activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. This
event may occur because PKC</A> stimulation<SUP> </SUP>diminishes the ability of
activated G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> proteins to associate<SUP> </SUP>with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">. To
investigate this possibility, we determined whether<SUP> </SUP>PKC</A> stimulation
alters the co-precipitation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB><SUP> </SUP>in
agonist-treated cells (Fig. <a href="#F6">6</a>). Carbachol
induces G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> to<SUP> </SUP>associate with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 (Fig.
<a href="#F6">6</a><I>A</I>, <I>lane 3</I>) and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (Fig. <a href="#F6">6</a><I>B</I>,
<I>lane<SUP> </SUP>3</I>). Treatment with PMA</A> completely abolishes the
carbachol-induced<SUP> </SUP>association of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3
(Fig. <a href="#F6">6</a><I>B</I>, <I>lane 6</I>). This result<SUP> </SUP>suggests that the
PKC-mediated phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 diminishes<SUP> </SUP>the interaction of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with the phospholipase. This response<SUP> </SUP>is not
restricted to signaling by the muscarinic receptor, because<SUP> </SUP>treatment
with PMA</A> also diminishes the ATP-induced association<SUP> </SUP>of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (Fig. <a href="#F6">6</a><I>B</I>,
<I>lane 5</I>). Treatment with PMA</A> does<SUP> </SUP>not alter the
agonist-induced association of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1<SUP> </SUP>(Fig.
<a href="#F6">6</a><I>A</I>, <I>lane 6</I>), consistent with our finding that PMA</A>
has no<SUP> </SUP>effect on PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 phosphorylation.



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=156 SRC="/content/vol275/issue50/images/small/bc4909341005.gif"></A><BR>

<STRONG>View larger version</STRONG> (22K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F5"
onClick="startTarget('F5', 590, 543); this.href='/cgi/content-nw/full/275/50/39767/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>PKC</B></A><B> inhibits PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
activation at a post-receptor step.</B> GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S-stimulated
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity was measured in membranes prepared from cells that had
been previously labeled with [<SUP>3</SUP>H]<I>myo</I>-inositol.
Prepared membranes were challenged with 100&nbsp;&#181;<font size=-1>M</font> GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S
for 10&nbsp;min, and the amount of released [<SUP>3</SUP>H]inositol
polyphosphates was measured as an indication of PLC activity. Results
show the means&nbsp;&#177;&nbsp;S.E. of a representative experiment repeated
three times.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







<BR CLEAR=ALL><A NAME="F6"><!-- FIG 6 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F6">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=170 SRC="/content/vol275/issue50/images/small/bc4909341006.gif"></A><BR>

<STRONG>View larger version</STRONG> (40K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F6">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F6"
onClick="startTarget('F6', 590, 574); this.href='/cgi/content-nw/full/275/50/39767/F6'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F6">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 6. &nbsp;</STRONG>

<B>PKC</B></A><B> activation inhibits the GPCR-induced
association of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but not with
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1.</B> CHO</A> cells were incubated in the
absence (<I>lanes 1-3</I>) or presence (<I>lanes 4-6</I>) of
50&nbsp;n<font size=-1>M</font> PMA</A> for 15&nbsp;min and then exposed to 10&nbsp;&#181;<font size=-1>M</font> ATP (<I>lanes 2</I>&nbsp;and <I>5</I>) or 10&nbsp;&#181;<font size=-1>M</font> carbachol (<I>lanes 3</I>&nbsp;and <I>6</I>) for 10&nbsp;min. G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> was immunoprecipitated from the cells after
protein cross-linking with dithiobis[succinimidyl propionate] and
subjected to ECL-Western blotting using antibodies to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1
(<I>A</I>), PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 (<I>B</I>), or G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>
(<I>A</I> and <I>B</I>). Similar results were obtained in two
other independent experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 6 -->




    
    </P>

    
    <P>To determine whether PKC</A> activation alters other aspects of receptor
signaling, the effects of PMA</A> on the agonist-induced<SUP> </SUP>activation of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> were investigated. Activation of P2Y<SUB>2</SUB>
receptors<SUP> </SUP>stimulates an approximately 500% increase in
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> activation,<SUP> </SUP>as indicated by the binding of
[<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S to G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> (Fig.
<a href="#F7">7</a><I>A</I>). This response is
unaffected by pretreatment<SUP> </SUP>with PMA</A> (Fig. <a href="#F7">7</a><I>A</I>). Similarly,
the M<SUB>3</SUB> mAChR-stimulated increase<SUP> </SUP>in G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>
activation is unaffected by PMA</A> pretreatment (Fig. <a href="#F7">7</a><I>A</I>).<SUP> </SUP>These findings indicate that the GPCR-dependent activation
of<SUP> </SUP>G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> is intact in PMA-treated cells. Consistent with
this result,<SUP> </SUP>we found that PMA</A> treatment actually enhances the ability
of the<SUP> </SUP>muscarinic receptor to activate phospholipase A<SUB>2</SUB>, as
indicated<SUP> </SUP>by arachidonic acid release (Fig. <a href="#F7">7</a><I>B</I>).



<BR CLEAR=ALL><A NAME="F7"><!-- FIG 7 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F7">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=161 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4909341007.gif"></A><BR>

<STRONG>View larger version</STRONG> (20K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F7">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F7"
onClick="startTarget('F7', 505, 640); this.href='/cgi/content-nw/full/275/50/39767/F7'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F7">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 7. &nbsp;</STRONG>

<B>PKC</B></A><B> activation does not impair the activation
of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> induced by
P2Y<SUB>2</SUB> receptors and M<SUB>3</SUB> </B><B>mAChR</B></A><B> or the
M<SUB>3</SUB> mAChR-induced activation of phospholipase
A<SUB>2</SUB>.</B> <I>A</I>, CHO</A> cells were incubated in the
absence or presence of 50&nbsp;n<font size=-1>M</font> PMA</A> for 10&nbsp;min and subjected
to a freeze/thaw cycle. The lysed cells were incubated with the
indicated concentrations of ATP or carbachol in the presence of 35&nbsp;n<font size=-1>M</font> [<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S for 10&nbsp;min and solubilized
for immunoprecipitation of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. The binding of
[<SUP>35</SUP>S]GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S to G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> was determined by
liquid scinitillation counting of the immunoprecipitated
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. Results show the means&nbsp;&#177;&nbsp;S.E. from a
representative experiment repeated three times. <I>B</I>, CHO</A> cells
labeled with [<SUP>3</SUP>H]arachidonic acid were incubated in the
absence or presence of 50&nbsp;n<font size=-1>M</font> PMA</A> for 10&nbsp;min. The cells were
challenged with the indicated concentrations of carbachol for 10&nbsp;min
and assayed for [<SUP>3</SUP>H]arachidonic acid release. Results
show the means&nbsp;&#177;&nbsp;S.E. from a representative experiment repeated
three times.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 7 -->




    
    </P>

    
    <P>The preceding results indicate that the GPCR-mediated activation of PKC</A>
stimulates PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation, resulting in reduced<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3
activity because of diminished interactions of the phosphorylated<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. This model predicts that the
activation of<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 by GPCR</A> should be enhanced when PKC</A> activity is
inhibited<SUP> </SUP>and diminished when PKC</A> activity is stimulated. To test this
prediction,<SUP> </SUP>we measured the effects of pharmacologically altering PKC</A>
activity<SUP> </SUP>on GPCR-mediated Ca<SUP>2+</SUP> mobilization, which is an
indicator of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity. We found<SUP> </SUP>that inactivation of PKC</A> with
BIM</A> enhances Ca<SUP>2+</SUP> mobilization induced by ATP (Fig.
<a href="#F8">8</a><I>A</I>) and carbachol (Fig.
<a href="#F8">8</a><I>B</I>).<SUP> </SUP>Conversely, activation of PKC</A> with PMA</A> diminishes
Ca<SUP>2+</SUP> mobilization induced by these agonists (Fig. <a href="#F8">8</a>). These
findings<SUP> </SUP>support the model that the PKC-mediated phosphorylation of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>diminishes the activity of the phospholipase.



<BR CLEAR=ALL><A NAME="F8"><!-- FIG 8 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F8">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=89 SRC="/content/vol275/issue50/images/small/bc4909341008.gif"></A><BR>

<STRONG>View larger version</STRONG> (16K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F8">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F8"
onClick="startTarget('F8', 590, 395); this.href='/cgi/content-nw/full/275/50/39767/F8'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F8">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 8. &nbsp;</STRONG>

<B>PKC</B></A><B> modulates Ca<SUP>2+</SUP> mobilization
induced by M<SUB>3</SUB> </B><B>mAChR</B></A><B> or P2Y<SUB>2</SUB> receptor
activation.</B> Ca<SUP>2+</SUP> mobilization induced by 10&nbsp;&#181;<font size=-1>M</font> ATP (<I>A</I>) or 0.5&nbsp;&#181;<font size=-1>M</font> carbachol
(<I>B</I>) was measured using CHO</A> cells that had been preincubated
for 10&nbsp;min with 10&nbsp;&#181;<font size=-1>M</font> BIM</A>, 50&nbsp;n<font size=-1>M</font> PMA</A>, or no
drug. Results are representative of three independent experiments that
produced similar results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 8 -->




    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>The purpose of this investigation was to characterize the
involvement of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> phosphorylation in the termination of
GPCR-dependent<SUP> </SUP>PLC activation. Activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> by
P2Y<SUB>2</SUB> receptors and M<SUB>3</SUB> mAChR</A><SUP> </SUP>was investigated
because these GPCRs are known to stimulate transient<SUP> </SUP>and sustained
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity, respectively. Our results indicate<SUP> </SUP>that activation of
these receptors induces the PKC-mediated phosphorylation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3.
This phosphorylation event may deactivate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 by<SUP> </SUP>inhibiting the
association of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with the phospholipase. In<SUP> </SUP>contrast, PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is not phosphorylated by PKC</A> and thus is not<SUP> </SUP>deactivated by this mechanism. Our results suggest that the activation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 by M<SUB>3</SUB> mAChR</A>, but not by P2Y<SUB>2</SUB>
receptors, may contribute<SUP> </SUP>to the sustained PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity induced by
M<SUB>3</SUB> mAChR</A> activation.<SUP> </SUP>This model is depicted in Fig.
<a href="#F9">9</a>.



<BR CLEAR=ALL><A NAME="F9"><!-- FIG 9 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/50/39767/F9">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=134 HEIGHT=200 SRC="/content/vol275/issue50/images/small/bc4909341009.gif"></A><BR>

<STRONG>View larger version</STRONG> (17K):
<BR><NOBR><A HREF="/cgi/content/full/275/50/39767/F9">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/50/39767/F9"
onClick="startTarget('F9', 444, 640); this.href='/cgi/content-nw/full/275/50/39767/F9'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F9">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 9. &nbsp;</STRONG>

<B>A model depicting how </B><B>PKC</B></A><B> may differentially
modulate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity induced by
M<SUB>3</SUB> </B><B>mAChR</B></A><B> or P2Y<SUB>2</SUB> receptor activation.</B>
M<SUB>3</SUB> mAChR</A> activate both PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 and a greater
proportion of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> than P2Y<SUB>2</SUB> receptors.
P2Y<SUB>2</SUB> receptors activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but show no detectable
activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1. Activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is
subject to PKC-mediated negative feedback inhibition, resulting in
rapid termination of receptor-activated PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 activity.
Phosphorylation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 results in a decreased association of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3. Selective activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 or
-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, together with selective PKC-mediated negative feedback
inhibition, provide at least a partial explanation of the mechanisms
allowing prolonged <I>versus</I> transient receptor-mediated
activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 9 -->




    
    </P>

    
    <P>The activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> by GPCRs typically surges and declines
rapidly (<A HREF="#B6">6-8</A>). The GPCR-induced activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> is usually<SUP> </SUP>detectable in just a few seconds and frequently peaks around 10-20<SUP> </SUP>s
before falling either to the base line or to a plateau level<SUP> </SUP>above the
base line. These changes in PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity are mirrored<SUP> </SUP>by similar
changes in [Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB> concentration. Negative
feedback inhibition of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "><SUP> </SUP>by PKC</A> is one mechanism that has been
proposed for the rapid termination<SUP> </SUP>of phosphatidylinositol
4,5-bisphosphate hydrolysis and [Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB>
mobilization (<A HREF="#B4">4</A>, <A HREF="#B17">17</A>, <A HREF="#B18">18</A>). However, investigations<SUP> </SUP>addressing the
effects of PKC</A> activation on the GPCR-activated<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> cascade have
been limited by the inability to conclusively<SUP> </SUP>pinpoint the site of PKC</A><SUP> </SUP>action.
    
    </P>

    
    <P>Because of the large number and complexity of components involved, PKC</A>
could act at many sites in the GPCR</A> signaling pathway<SUP> </SUP>to limit PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">
activity. Direct activation of PKC</A> with PMA</A> is<SUP> </SUP>known to induce the
phosphorylation of M<SUB>3</SUB> mAChR</A>, with undetermined<SUP> </SUP>effects on
M<SUB>3</SUB> mAChR</A> function (<A HREF="#B12">12</A>). This finding, along with<SUP> </SUP>demonstrations that some other GPCRs can be phosphorylated by<SUP> </SUP>PKC</A> (<A HREF="#B22">22</A>,
<A HREF="#B23">23</A>), led to the speculation that PKC</A> activation inhibits<SUP> </SUP>events at the
receptor level. However, we found that activation<SUP> </SUP>of PKC</A> with PMA</A> does
not alter the ability of M<SUB>3</SUB> mAChR</A> or P2Y<SUB>2</SUB><SUP> </SUP>receptors to activate G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. This result indicates that
PKC</A> inhibits<SUP> </SUP>a post-receptor event. Consistent with this conclusion, we
found<SUP> </SUP>that PKC</A> activation inhibits IP<SUB>3</SUB></A> generation that is
induced by<SUP> </SUP>directly activating G proteins with GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S, without
involving GPCRs.<SUP> </SUP>These findings indicate that PKC</A> inhibits the GPCR</A>
signaling cascade<SUP> </SUP>only at a point after the activation of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>.
    
    </P>

    
    <P>Our studies show that PKC</A> activation induces the phosphorylation of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 and diminishes the ability of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 to interact<SUP> </SUP>with
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. In contrast, PKC</A> activation does not induce the
phosphorylation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, nor does it affect the ability of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1
to associate<SUP> </SUP>with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. These findings suggest that PKC</A>
inhibits PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 activity<SUP> </SUP>by phosphorylating PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 and diminishing
the ability of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>to interact with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>. Although
PKC</A> activation may inhibit other<SUP> </SUP>events following PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation,
our results indicate that the<SUP> </SUP>PKC-mediated inhibition of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 interactions is one<SUP> </SUP>way that the GPCR</A>
signaling cascade can be<SUP> </SUP>deactivated.
    
    </P>

    
    <P>It is intriguing that PKC</A> activation induces phosphorylation of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1. The reason for the lack of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1
phosphorylation<SUP> </SUP>is unknown. It is unlikely that any differences in the
intracellular<SUP> </SUP>compartmentalization of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 contribute
to their<SUP> </SUP>different phosphorylation profiles in CHO-m3 cells, because
PMA</A><SUP> </SUP>probably has equal access to different intracellular sites. It<SUP> </SUP>is
conceivable that PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, but not PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, is associated
intracellularly<SUP> </SUP>with protein partners that protect it from PKC-mediated
phosphorylation,<SUP> </SUP>although evidence for this possibility is<SUP> </SUP>lacking.
    
    </P>

    
    <P>Activation of PKA</A>, rather than PKC</A>, has been found to induce PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3
phosphorylation in some systems (<A HREF="#B19">19</A>). This PKA-mediated<SUP> </SUP>phosphorylation
of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 would represent cross-regulation between<SUP> </SUP>GPCRs that signal
through adenylyl cyclase- and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-mediated<SUP> </SUP>pathways and not
negative feedback control. This distinction is<SUP> </SUP>critical because
PKC-mediated negative feedback can be a mechanism<SUP> </SUP>for the termination
of PLC activity. In contrast, PKA-mediated<SUP> </SUP>cross-regulation is unlikely
to be a mechanism for the termination<SUP> </SUP>of PLC activity because
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>-coupled GPCRs do not generally<SUP> </SUP>activate adenylyl
cyclase. We demonstrated that PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation<SUP> </SUP>induced by
P2Y<SUB>2</SUB> receptors or M<SUB>3</SUB> mAChR</A> is not mediated by
the action<SUP> </SUP>of PKA</A> nor by an increase in cAMP. Agents that elevate cAMP
do<SUP> </SUP>not affect PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation by these receptors. Similarly, it<SUP> </SUP>was
previously reported that signaling by the platelet-activating<SUP> </SUP>factor
receptor, which activates PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> via G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> and induces<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 phosphorylation, is insensitive to the action of forskolin<SUP> </SUP>or
other PKA-activating agents (<A HREF="#B30">30</A>). However, we did find that<SUP> </SUP>agents that
increase cAMP can stimulate modest increases in PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3<SUP> </SUP>phosphorylation (typically 1.5-fold). It is possible that PKA</A><SUP> </SUP>regulates
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity only when PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> is activated by specific<SUP> </SUP>GPCR-mediated signals that differ from those generated by
M<SUB>3</SUB> mAChR</A><SUP> </SUP>or P2Y<SUB>2</SUB> receptor stimulation in CHO</A>
cells. This possibility is<SUP> </SUP>supported by a previous report that PKA</A>
activation alters signaling<SUP> </SUP>by the formyl peptide receptor (<A HREF="#B30">30</A>), which
activates PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> via<SUP> </SUP>G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>i</SUB> rather than via
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB>.
    
    </P>

    
    <P>The differential coupling of M<SUB>3</SUB> mAChR</A> and P2Y<SUB>2</SUB>
receptors to PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 was somewhat surprising. Whereas the
stimulation<SUP> </SUP>of M<SUB>3</SUB> mAChR</A> induced the interaction of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 and<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, the stimulation of
P2Y<SUB>2</SUB> receptors only induced the interaction<SUP> </SUP>of
G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> with PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3. These differences may occur because
greater<SUP> </SUP>levels of G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> are activated by stimulating
M<SUB>3</SUB> mAChR</A> than by<SUP> </SUP>stimulating P2Y<SUB>2</SUB> receptors in
these cells. Stimulation of P2Y<SUB>2</SUB><SUP> </SUP>receptors may not activate
enough G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> to allow the detectable<SUP> </SUP>association of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 with G<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUB>q/11</SUB> in our assays. Alternatively,<SUP> </SUP>it is
possible that PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1 is located in unique intracellular<SUP> </SUP>sites that
make it more susceptible to activation by M<SUB>3</SUB> mAChR</A><SUP> </SUP>than by
P2Y<SUB>2</SUB><SUP> </SUP>receptors.
    
    </P>

    
    <P>Our results suggest an explanation for the ability of the
M<SUB>3</SUB> mAChR</A> to induce sustained PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation. Sustained
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity<SUP> </SUP>is induced by stimulating endogenous M<SUB>3</SUB>
mAChR</A> in cultured neuronal<SUP> </SUP>and lung cancer cell lines (<A HREF="#B6">6</A>, <A HREF="#B9">9</A>),
indicating that sustained<SUP> </SUP>activation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> is not simply a result
of nonphysiological<SUP> </SUP>signaling by transfected mAChR</A>. Instead, our
results suggest that<SUP> </SUP>sustained PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation may be induced by
M<SUB>3</SUB> mAChR</A> because<SUP> </SUP>these receptors activate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">1, which
is not susceptible to PKC-dependent<SUP> </SUP>inhibition. In
contrast, only transient PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activation may be<SUP> </SUP>induced by
P2Y<SUB>2</SUB> receptors because these receptors activate only<SUP> </SUP>PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, which is susceptible to PKC-mediated inhibition. We found<SUP> </SUP>that inactivation of PKC</A> with BIM</A> converts P2Y<SUB>2</SUB>
receptor-mediated<SUP> </SUP>[Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB> mobilization from a
transient event to a sustained<SUP> </SUP>event. According to our model, treatment
with BIM</A> diminishes the<SUP> </SUP>PKC-mediated inhibition of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3, resulting
in prolonged activation<SUP> </SUP>of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">3 and sustained
[Ca<SUP>2+</SUP>]<SUB><I>i</I></SUB> mobilization after P2Y<SUB>2</SUB>
receptor activation. In addition<SUP> </SUP>to this PKC-mediated regulation of
PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, other negative and positive<SUP> </SUP>feedback events undoubtedly
contribute to the different abilities<SUP> </SUP>of the M<SUB>3</SUB> mAChR</A> and
P2Y<SUB>2</SUB> receptor to regulate PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity.<SUP> </SUP>However, the
activation of specific PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> isoforms that have different<SUP> </SUP>susceptibilities to PKC-mediated inhibition provides an intriguing<SUP> </SUP>mechanism for the temporal regulation of PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> activity by<SUP> </SUP>GPCRs.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We thank Scott Phelps and Rebecca
Ruiz-Velasco for expert technical<SUP> </SUP>assistance.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was funded by the American Heart Association
(Pennsylvannia and Delaware Affiliate) and by the Arthur T.&nbsp;Cantwell<SUP> </SUP>Charitable Foundation.The costs of publication of this
article<SUP> </SUP>were defrayed in part by the
payment of page charges. The article<SUP> </SUP>must therefore be hereby marked
"<I>advertisement</I>" in
accordance<SUP> </SUP>with 18&nbsp;U.S.C. Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN152"><SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP></A>
To whom correspondence should be addressed: Molecular
Pharmacology Lab., Guthrie Research Inst., One Guthrie Square, Sayre,<SUP> </SUP>PA 18840.&nbsp;Tel.: 570-882-4650; Fax: 570-882-5151; E-mail:
cwilliam@inet.guthrie.org.

<P>


<P>
Published, JBC Papers in Press, September 19,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M007775200

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

PLC-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">, phosholipase C-<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">;

BIM, bisindolylmaleimide I;

CHO, Chinese hamster
ovary;

GPCR, G protein-coupled receptor;

GTP<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">S, guanosine
5'-O-(3-thiotriphosphate);

IP<SUB>3</SUB>, inositol (<A HREF="#B1">1</A>, <A HREF="#B4">4</A>,
<A HREF="#B5">5</A>)-trisphosphate;

mAChR, muscarinic acetylcholine receptor;

PMA, phorbol 12-myristate 13-acetate;

PKA, protein kinase A;

PKC, protein
kinase C;

PAGE, polyacrylamide gel electrophoresis;

PVDF, polyvinylidene difluoride.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<BR CLEAR=ALL><TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Berridge, M. J.



(1993)

<I>Nature</I>
<B>361</B>,
315-325<!-- HIGHWIRE ID="275:50:39767:1" --><A HREF="/cgi/external_ref?access_num=8381210&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8381210&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Exton, J. H.



(1996)

<I>Annu. Rev. Pharmacol. Toxicol.</I>
<B>36</B>,
481-509<!-- HIGHWIRE ID="275:50:39767:2" --><A HREF="/cgi/external_ref?access_num=10.1146/annurev.pharmtox.36.1.481&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8725399&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8725399&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Williams, R. L.



(1999)

<I>Biochim. Biophys. Acta</I>
<B>1441</B>,
255-267<!-- HIGHWIRE ID="275:50:39767:3" --><A HREF="/cgi/external_ref?access_num=10570253&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10570253&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>Nishizuka, Y.&nbsp;(1995) <I>FASEB, J</I> ,&nbsp;484-496
    <!-- HIGHWIRE ID="275:50:39767:4" --><!-- /HIGHWIRE --></TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Rhee, S. G.,
 and Bae, Y. S.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
15045-15048<!-- HIGHWIRE ID="275:50:39767:5" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=jbc&resid=272/24/15045"><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Los, G. V.,
Artemenko, I. P.,
 and Hokin, L. E.



(1995)

<I>Biochem, J.</I>
<B>311</B>,
225-232<!-- HIGHWIRE ID="275:50:39767:6" --><A HREF="/cgi/external_ref?access_num=7575458&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7575458&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Plevin, R.,
MacNulty, E. E.,
Palmer, S.,
 and Wakelam, M. J.



(1991)

<I>Biochem. J.</I>
<B>280</B>,
609-615<!-- HIGHWIRE ID="275:50:39767:7" --><A HREF="/cgi/external_ref?access_num=1764024&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1764024&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Willars, G. B.,
McArdel, C. A.,
 and Nahorski, S. R.



(1998)

<I>Biochem. J.</I>
<B>333</B>,
301-308<!-- HIGHWIRE ID="275:50:39767:8" --><A HREF="/cgi/external_ref?access_num=9657969&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9657969&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Williams, C.,
 and Lennon, V.



(1990)

<I>J. Biol. Chem.</I>
<B>265</B>,
1443-1447<!-- HIGHWIRE ID="275:50:39767:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/3/1443"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Rosado, J. A.,
 and Sage, S. O.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
9110-9113<!-- HIGHWIRE ID="275:50:39767:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/13/9110"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Strassheim, D.,
May, L. G.,
Varker, K. A.,
Puhl, H. L.,
Phelps, S. H.,
Porter, R. A.,
Aronstam, R. S.,
Noti, J. D.,
 and Williams, C. L.



(1999)

<I>J. Biol. Chem.</I>
<B>274</B>,
18675-18685<!-- HIGHWIRE ID="275:50:39767:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=274/26/18675"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Tobin, A. B.



(1997)

<I>Pharmacol. Ther.</I>
<B>75</B>,
135-151<!-- HIGHWIRE ID="275:50:39767:12" --><A HREF="/cgi/external_ref?access_num=10.1016/S0163-7258(97)00053-3&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9428002&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9428002&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Premont, R. T.,
Inglese, J.,
 and Lefkowitz, R. J.



(1995)

<I>FASEB J.</I>
<B>9</B>,
175-182<!-- HIGHWIRE ID="275:50:39767:13" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=9/2/175">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Watson, N.,
Linder, M. E.,
Druey, K. M.,
Kehrl, J. H.,
 and Blumer, K. J.



(1996)

<I>Nature</I>
<B>383</B>,
172-175<!-- HIGHWIRE ID="275:50:39767:14" --><A HREF="/cgi/external_ref?access_num=8774882&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8774882&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Dohlman, H. G.,
 and Thorner, J.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
3871-3874<!-- HIGHWIRE ID="275:50:39767:15" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=jbc&resid=272/7/3871"><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Berstein, G.,
Blank, J. L.,
Jhon, D. Y.,
Exton, J. H.,
Rhee, S. G.,
 and Ross, E. M.



(1992)

<I>Cell.</I>
<B>70</B>,
411-418<!-- HIGHWIRE ID="275:50:39767:16" --><A HREF="/cgi/external_ref?access_num=1322796&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=1322796&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Ali, H.,
Fisher, I.,
Haribabu, B.,
Richardson, R. M.,
 and Snyderman, R.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
11706-11709<!-- HIGHWIRE ID="275:50:39767:17" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/18/11706"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Strassheim, D.,
Law, P. Y.,
 and Loh, H. H.



(1998)

<I>Mol. Pharmacol.</I>
<B>53</B>,
1047-1053<!-- HIGHWIRE ID="275:50:39767:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=molpharm&resid=53/6/1047"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Yue, C.,
Dodge, K. L.,
Weber, G.,
 and Sanborn, B. M.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
18023-18027<!-- HIGHWIRE ID="275:50:39767:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/29/18023"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Plevin, R.,
Palmer, S.,
Gardner, S. D.,
 and Wakelam, M. J.



(1990)

<I>Biochem, J.</I>
<B>268</B>,
605-610<!-- HIGHWIRE ID="275:50:39767:20" --><A HREF="/cgi/external_ref?access_num=2114096&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=2114096&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Ryu, S. H.,
Kim, U. H.,
Matthew, I.,
Wahl, I.,
Brown, A. B.,
Carpenter, G.,
Huang, K. P.,
 and Rhee, S. G.



(1990)

<I>J. Biol. Chem.</I>
<B>265</B>,
17941-17945<!-- HIGHWIRE ID="275:50:39767:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=265/29/17941"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Vazquez-Prado, J.,
Medina, L. C.,
Romero-Avila, M. T.,
Gonzalez-Espinsoa, C.,
 and Garcia-Sainz, J. A.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
6553-6559<!-- HIGHWIRE ID="275:50:39767:22" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/9/6553"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Hipkin, R. W.,
Wang, Y.,
 and Schonbrunn, A.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
5591-5599<!-- HIGHWIRE ID="275:50:39767:23" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/8/5591"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Parekh, A. B.,
 and Penner, R.



(1995)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>92</B>,
7907-7911<!-- HIGHWIRE ID="275:50:39767:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=92/17/7907">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Dickenson, J. M.,
Blank, J. L.,
 and Hill, S. J.



(1998)

<I>Br. J.&nbsp;Pharmacol</I>
<B>124</B>,
1491-1499<!-- HIGHWIRE ID="275:50:39767:25" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=brjpharmacol&resid=124/7/1491">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Strassheim, D.,
Shafer, S. H,
Phelps, S. H.,
 and Williams, C. L.



(2000)

<I>Cancer Res.</I>
<B>60</B>,
2730-2736<!-- HIGHWIRE ID="275:50:39767:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=canres&resid=60/10/2730"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Murthy, K. S.,
 and Makhlouf, G. M.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
4695-4704<!-- HIGHWIRE ID="275:50:39767:27" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/8/4695"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

May, L. G.,
Johnson, S.,
Krebs, S.,
Newman, A.,
 and Aronstam, R. S.



(1999)

<I>Cell. Signaling</I>
<B>11</B>,
179-187<!-- HIGHWIRE ID="275:50:39767:28" --><A HREF="/cgi/external_ref?access_num=10.1016/S0898-6568(98)00053-9&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10353692&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10353692&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Adamson, D. L.,
 and Harding, S. E.



(2000)

<I>Basic. Res. Cardiol.</I>
<B>95</B>,
114-118<!-- HIGHWIRE ID="275:50:39767:29" --><A HREF="/cgi/external_ref?access_num=10.1007/s003950050172&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10826503&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10826503&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Ali, H.,
Sozzani, S.,
Fischer, I.,
Barr, A. J.,
Richardson, R. M.,
Haribabu, B.,
 and Snyderman, R.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
11012-11016<!-- HIGHWIRE ID="275:50:39767:30" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/18/11012"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.brjpharmacol.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.brjpharmacol.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.brjpharmacol.org"><IMG ALT="Br. J. Pharmacol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/brjpharmacol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Lindqvist, J. Hernon, P. Sharp, N. Johns, S. Addison, M. Watson, R. Tighe, S. Greer, J. Mackay, M. Rhodes, M. Lewis, W. Stebbings, C. Speakman, S. Evangelista, I. Johnson, and M. Williams<BR>
	<STRONG>The colon-selective spasmolytic otilonium bromide inhibits muscarinic M3 receptor-coupled calcium signals in isolated human colonic crypts</STRONG><BR>
	
		
			Br. J. Pharmacol.,
		
	
        
        December&nbsp;7,&nbsp;2002;
	137(7):
	1134 - 1142.
<BR>
<A HREF="http://www.brjpharmacol.org/cgi/content/abstract/137/7/1134">[Abstract]</A>

<A HREF="http://www.brjpharmacol.org/cgi/content/full/137/7/1134">[Full Text]</A>
<A HREF="http://www.brjpharmacol.org/cgi/reprint/137/7/1134">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. L. Moore, M. W. Roe, R. F. Melnick, and S. D. Lidofsky<BR>
	<STRONG>Calcium Mobilization Evoked by Hepatocellular Swelling Is Linked to Activation of Phospholipase Cgamma</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        September&nbsp;13,&nbsp;2002;
	277(37):
	34030 - 34035.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/37/34030">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/37/34030">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/37/34030">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. F. Arthur, S. J. Matkovich, C. J. Mitchell, T. J. Biden, and E. A. Woodcock<BR>
	<STRONG>Evidence for Selective Coupling of alpha 1-Adrenergic Receptors to Phospholipase C-beta 1 in Rat Neonatal Cardiomyocytes</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;5,&nbsp;2001;
	276(40):
	37341 - 37346.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/40/37341">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/40/37341">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/40/37341">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/50/39767">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/50/39767">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/50/39767">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/50/39767&title=P2Y2+Purinergic+and+M3+Muscarinic+Acetylcholine+Receptors+Activate+Different+Phospholipase+C-beta++Isoforms+That+Are+Uniquely+Susceptible+to+Protein+Kinase+C-dependent+Phosphorylation+and+Inactivation">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M007775200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10995776&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10995776&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Strassheim+D&link_type=AUTHORSEARCH">Strassheim, D.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Williams+CL&link_type=AUTHORSEARCH">Williams, C. L.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/50/39767&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F50%2F39767"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/50/39767">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/50/39767<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M007775200v1">M007775200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue50/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
